Fenoverine: Difference between revisions

Browse history interactively ← Previous edit Next edit →Content deleted Content addedVisual WikitextInline

Revision as of 22:29, 11 August 2011 editCheMoBot (talk \| contribs)Bots141,565 edits Updating {{drugbox}} (no changed fields - added verified revid - updated 'ChemSpiderID_Ref', 'DrugBank_Ref', 'ChEMBL_Ref', 'ChEBI_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'ChEBI_Ref') per [[Misplaced Pages:WikiProject Chemicals/Chembox validation\|Chem/Drug← Previous edit		Revision as of 22:31, 2 September 2011 edit undoBogBot (talk \| contribs)Bots53,132 edits populated new fields in {{drugbox}} and reordered per bot approval. Report errors and suggestions to User_talk:BogBot Next edit →
Line 1:		Line 1:
	{{~~drugbox~~		{{Drugbox
⚫	\| UNII_Ref = {{fdacite\|correct\|FDA}}
⚫	\| UNII = N274ZQ6PZJ
	\| verifiedrevid = 437188857		\| verifiedrevid = 437188857
	\| IUPAC_name = 2-dioxol-5-ylmethyl)piperazin-1-yl]-1-(10''H''-phenothiazin-10-yl)ethanone		\| IUPAC_name = 2-dioxol-5-ylmethyl)piperazin-1-yl]-1-(10''H''-phenothiazin-10-yl)ethanone
	\| image = Fenoverine.svg		\| image = Fenoverine.svg

⚫	\| CAS_number = 37561-27-6
			<!--Clinical data-->
⚫	\| ATC_prefix = A03
			\| tradename =
⚫	\| ATC_suffix = AX05
			\| Drugs.com = {{drugs.com\|international\|fenoverine}}
⚫	\| PubChem = 72098
		⚫	\| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
		⚫	\| pregnancy_US = <!-- A / B / C / D / X -->
		⚫	\| pregnancy_category =
		⚫	\| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
		⚫	\| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
		⚫	\| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
		⚫	\| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
		⚫	\| legal_status =
		⚫	\| routes_of_administration =

			<!--Pharmacokinetic data-->
		⚫	\| bioavailability =
		⚫	\| protein_bound =
		⚫	\| metabolism =
		⚫	\| elimination_half-life =
		⚫	\| excretion =

			<!--Identifiers-->
		⚫	\| CAS_number = 37561-27-6
		⚫	\| ATC_prefix = A03
		⚫	\| ATC_suffix = AX05
		⚫	\| PubChem = 72098
	\| DrugBank_Ref = {{drugbankcite\|correct\|drugbank}}		\| DrugBank_Ref = {{drugbankcite\|correct\|drugbank}}
	\| DrugBank =		\| DrugBank =
		⚫	\| UNII_Ref = {{fdacite\|correct\|FDA}}
		⚫	\| UNII = N274ZQ6PZJ
	\| KEGG_Ref = {{keggcite\|correct\|kegg}}		\| KEGG_Ref = {{keggcite\|correct\|kegg}}
	\| KEGG = D07095		\| KEGG = D07095

⚫	\| chemical_formula =
			<!--Chemical data-->
⚫	\| C=26 \| H=15 \| N=3 \| O=3 \| S=1
		⚫	\| chemical_formula =
⚫	\| molecular_weight = 459.56 g/mol
		⚫	\| C=26 \| H=15 \| N=3 \| O=3 \| S=1
⚫	\| smiles = C1CN(CCN1CC2=CC3=C(C=C2)OCO3)CC(=O)N4C5=CC=CC=C5SC6=CC=CC=C64
		⚫	\| molecular_weight = 459.56 g/mol
⚫	\| bioavailability =
		⚫	\| smiles = C1CN(CCN1CC2=CC3=C(C=C2)OCO3)CC(=O)N4C5=CC=CC=C5SC6=CC=CC=C64
⚫	\| protein_bound =
⚫	\| metabolism =
⚫	\| elimination_half-life =
⚫	\| excretion =
⚫	\| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
⚫	\| pregnancy_US = <!-- A / B / C / D / X -->
⚫	\| pregnancy_category=
⚫	\| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
⚫	\| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
⚫	\| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
⚫	\| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
⚫	\| legal_status =
⚫	\| routes_of_administration =
	}}		}}
	'''Fenoverine''' (]) is an ] drug.		'''Fenoverine''' (]) is an ] drug.

Revision as of 22:31, 2 September 2011

Pharmaceutical compound

Fenoverine
Clinical data

AHFS/Drugs.com	International Drug Names
ATC code	A03AX05 (WHO)
Identifiers
IUPAC name 2-dioxol-5-ylmethyl)piperazin-1-yl]-1-(10H-phenothiazin-10-yl)ethanone
CAS Number	37561-27-6
PubChem CID	72098
UNII	N274ZQ6PZJ
KEGG	D07095
CompTox Dashboard (EPA)	DTXSID8046296
ECHA InfoCard	100.048.666
Chemical and physical data
Formula	C₂₆H₁₅N₃O₃S
Molar mass	459.56 g/mol g·mol
3D model (JSmol)	Interactive image
SMILES C1CN(CCN1CC2=CC3=C(C=C2)OCO3)CC(=O)N4C5=CC=CC=C5SC6=CC=CC=C64
(verify)

Fenoverine (INN) is an antispasmodic drug.

Drugs for functional gastrointestinal disorders (A03)

Drugs for
functional
bowel
disorders

Antimuscarinics

Tertiary amino group	Camylofin Dicycloverine Difemerine Dihexyverine Mebeverine Oxyphencyclimine Piperidolate Rociverine Trimebutine
Quaternary ammonium compounds	Benzilone Bevonium Diphemanil Fenpiverinium Glycopyrronium Hexocyclium Isopropamide Mepenzolate Methantheline Otilonium Oxyphenonium Penthienate Pipenzolate Poldine Prifinium Propantheline Tiemonium Timepidium Tridihexethyl

Phosphodiesterase
inhibitors

Acting on
serotonin receptors

Other

Belladonna
and derivatives
(antimuscarinics)

Tertiary amines: Atropine
Hyoscyamine

Propulsives

This drug article relating to the gastrointestinal system is a stub. You can help Misplaced Pages by expanding it.

Categories: